Skip to main content
Top
Published in: Digestive Diseases and Sciences 2/2021

01-02-2021 | Tarry Feces | UNM CLINICAL CASE CONFERENCES

Distress in the Duodenum: Diagnosis by Deduction

Authors: Negar Yaghooti, Jawairia Memon, Nicholas Volpicelli, Jason Funderburk, Denis McCarthy

Published in: Digestive Diseases and Sciences | Issue 2/2021

Login to get access

Excerpt

A 42-year-old man was evaluated by our hospital with a 3-week history of epigastric abdominal pain and melena. He described the abdominal pain as intermittent, dull, 4/10 in intensity, non-radiating, and with no aggravating or relieving factors. He also reported 2–3 episodes of melena daily for 3 weeks, nausea and non-bloody emesis, unrelated to eating. He had been admitted 1 year previously with severe alcohol-related necrotizing pancreatitis. Though he had quit alcohol for several months after this first admission, he had relapsed and reported drinking 1 pint of whiskey up to 3 days prior to admission. He also reported falling while skiing 1 month prior and said that he was taking ibuprofen 600 mg up to twice a day for aches in his extremities. The only other medication he reported taking was omeprazole 20 mg once a day for heartburn. Aside from melena on rectal examination, his physical examination and vital signs were unremarkable. Nevertheless, laboratory evaluation revealed a hemoglobin of 8.8 g/dL (13.8–17.2 g/dL), reduced from 13.3 g/dL 1 year ago, with MCV 98 fl (81–101 fl), RDW 13.3% (11–14.5%). His liver enzymes were unremarkable. Computed tomographic (CT) scan of the abdomen showed changes of acute pancreatitis with focal necrosis involving the distal pancreatic body and tail, as well as an incidental finding of partial thrombosis of the splenic vein. Given the presentation of melena, a fall in hemoglobin concentration, and a history of using ibuprofen, a peptic ulcer was suspected as the cause of bleeding. On the second hospital day, esophagogastroduodenoscopy (EGD) was performed; this revealed no source of bleeding in the esophagus or stomach, but in the duodenum active extravasation of blood from the duodenal papilla was observed. Upon close examination, it appeared that there was also an intermittent flow of clear bile, suggesting that the pancreas, and not the liver, was the bleeding source, i.e., the presence of hemosuccus pancreaticus. Given the history of pancreatitis, a ruptured pseudoaneurysm was suspected. At CT angiography, the ruptured vessel was identified as the pancreaticoduodenal artery (PDA) where it arose from the gastroduodenal artery (GDA) (Fig. 1). Using selective angiography, an interventional radiologist treated the area of bleeding by embolizing coils to the pancreaticoduodenal and gastroduodenal arteries (Figs. 2, 3). Two days later, CT angiography showed no evidence of a pseudoaneurysm, vascular lesion, or continuing hemorrhage. Six months after embolization and discharge from hospital, the patient remains well.
Literature
1.
go back to reference Grisendi A, Lonardo A, Della Casa G, et al. Hemoductal pancreatitis secondary to gastroduodenal artery-ruptured pseudoaneurysm: a rare cause of hematemesis. Am J Gastroenterol. 1991;86:1654–1657.PubMed Grisendi A, Lonardo A, Della Casa G, et al. Hemoductal pancreatitis secondary to gastroduodenal artery-ruptured pseudoaneurysm: a rare cause of hematemesis. Am J Gastroenterol. 1991;86:1654–1657.PubMed
4.
go back to reference Woods MS, Traverso LW, Kozarek RA, et al. Successful treatment of bleeding pseudoaneurysms of chronic pancreatitis. Pancreas. 1995;10:22–30.CrossRef Woods MS, Traverso LW, Kozarek RA, et al. Successful treatment of bleeding pseudoaneurysms of chronic pancreatitis. Pancreas. 1995;10:22–30.CrossRef
5.
go back to reference Kiviluoto T, Kivisaari L, Kivilaakso E, Lempinen M. Pseudocysts in chronic pancreatitis. Surgical results in 102 consecutive patients. Arch Surg. 1989;124:24&3.CrossRef Kiviluoto T, Kivisaari L, Kivilaakso E, Lempinen M. Pseudocysts in chronic pancreatitis. Surgical results in 102 consecutive patients. Arch Surg. 1989;124:24&3.CrossRef
6.
go back to reference Sankaran S, Walt AJ. The natural and unnatural history of pancreatic pseudocysts. Br J Surg. 1975;62:3704.CrossRef Sankaran S, Walt AJ. The natural and unnatural history of pancreatic pseudocysts. Br J Surg. 1975;62:3704.CrossRef
8.
go back to reference Rich A, Duff GL. Experimental and pathological studies on the pathogenesis of acute haemorrhagic pancreatitis. Bull Johns Hopkins Hosp. 1936;58:212–259. Rich A, Duff GL. Experimental and pathological studies on the pathogenesis of acute haemorrhagic pancreatitis. Bull Johns Hopkins Hosp. 1936;58:212–259.
12.
go back to reference Nemakayala D, Ling X, Laird-Fick H. FACP1 gastroduodenal artery pseudoaneurysm: a complication of pancreatitis. Am J Gastroenterol. 2017;112:S689.CrossRef Nemakayala D, Ling X, Laird-Fick H. FACP1 gastroduodenal artery pseudoaneurysm: a complication of pancreatitis. Am J Gastroenterol. 2017;112:S689.CrossRef
14.
go back to reference Han B, Song ZF, Sun B. Hemosuccus pancreaticus: a rare cause of gastrointestinal bleeding. Hepatobiliary Pancreat Dis Int. 2012;11:479–488.CrossRef Han B, Song ZF, Sun B. Hemosuccus pancreaticus: a rare cause of gastrointestinal bleeding. Hepatobiliary Pancreat Dis Int. 2012;11:479–488.CrossRef
15.
go back to reference Okuno A, Miyazaki M, Ito H, et al. Nonsurgical management of ruptured pseudoaneurysm in patients with hepatobiliary pancreatic diseases, 2001. Am J Gastroenterol. 2001;96:1067–1071.CrossRef Okuno A, Miyazaki M, Ito H, et al. Nonsurgical management of ruptured pseudoaneurysm in patients with hepatobiliary pancreatic diseases, 2001. Am J Gastroenterol. 2001;96:1067–1071.CrossRef
Metadata
Title
Distress in the Duodenum: Diagnosis by Deduction
Authors
Negar Yaghooti
Jawairia Memon
Nicholas Volpicelli
Jason Funderburk
Denis McCarthy
Publication date
01-02-2021
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2021
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06758-6

Other articles of this Issue 2/2021

Digestive Diseases and Sciences 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine